Pregabalin Capsule 150 mg (Pregabalin)

Adult dose

This medication is pregabalin, administered orally in divided doses twice daily, irrespective of food. 1. Neuropathic Pain 1) Peripheral Neuropathic Pain: Starting dose of 150 mg per day, can be increased to 300 mg per day after 3 to 7 days; if necessary, further increases to a maximum of 600 mg per day can be made at 7-day intervals. 2) Central Neuropathic Pain: Starting dose of 150 mg per day, can be increased to 300 mg per day after one week.

Child dose

Use in children under 12 years old and adolescents aged 12 to 17 is not recommended due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behavior, so patients should be closely monitored for changes in mood or symptoms of depression while taking it. Patients with allergies to pregabalin or this medication's components should not take this medication. Diabetic patients should be cautious because this medication may require adjustments in their blood sugar control medications due to possible weight gain after taking it. If symptoms of angioedema, such as swelling of the face or around the mouth, occur, the medication should be discontinued immediately and a doctor consulted. The elderly should be especially careful when taking this medication as dizziness or drowsiness may increase the risk of falls at the beginning of treatment. Transient blurriness or changes in vision may occur; if these symptoms persist, consult a doctor. Care should be taken when switching from other anticonvulsants to monotherapy. Abrupt discontinuation may result in withdrawal symptoms such as insomnia, headache, nausea, anxiety, depression, and suicidal thoughts, so the dose should be gradually reduced as per a doctor's instructions. Due to the risk of substance abuse, special caution is necessary in patients with a history of mental illness or substance abuse. Patients with reduced kidney function may need dose adjustments. Patients with severe heart disease should use this medication cautiously due to possible heart failure risks. When taken with other central nervous system depressants or opioids, there may be an increased risk of respiratory depression. Women of childbearing age should use effective contraception due to the risk of fetal malformations in early pregnancy, and the medication should generally be avoided during pregnancy. During breastfeeding, this medication may pass into breast milk and affect infants, so the decision to breastfeed or take the medication should be made carefully. Activities like driving or operating machinery should be avoided until dizziness or drowsiness resolves after taking this medication. Severe skin reactions may rarely occur; if skin rashes or fever occur, discontinue the medication immediately and consult a healthcare professional. In case of overdose, symptoms such as confusion, drowsiness, depression, or seizures may appear, so immediate medical attention should be sought.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, paleness, severe rash with fever, blisters, peeling skin, pain in mucous membranes of the mouth or eyes, shortness of breath, asthmatic attacks, cough with fever and respiratory abnormalities, yellowing of the skin or eyes (jaundice), severe lethargy, sudden and severe headaches, lightning headaches, seizures, confusion, vision abnormalities, paralysis, urinary symptoms.

Mild side effects

• Dizziness
• drowsiness
• rhinitis
• increased appetite
• decreased appetite
• hypoglycemia
• confusion
• disorientation
• irritability
• depression

This medication should be stored in a tightly closed container to protect from air and moisture, ideally at room temperature between 15 to 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness and prevents degradation.

Appearance

A hard capsule of white powder, with the upper and lower parts being white.

Package unit

30 capsules/bottle, 100 capsules/bottle